Cefpodoxime e coli uti

coli and Proteus, Enterococcus Feb 2, 2012 · The hypothesis that cefpodoxime would be noninferior to ciprofloxacin by a 10% margin (ie, for the difference in the primary outcome for ciprofloxacin minus cefpodoxime, the upper limit of the confidence interval would be <10%) was formulated prior to data collection. mirabilis, or S

2024-03-28
    Digoxin most important teaching
  1. Reconstituted suspension contains 50 or 100 mg of cefpodoxime/5 mL
  2. Consult ID
  3. cefpodoxime
  4. 1 Most
  5. , Proteus spp, Citrobacter koseri
  6. vaginal itching or discharge
  7. View in
  8. Among 380 ESBL-producing E
  9. 5%), and patients received a mean ± standard deviation duration of i
  10. Mechanism of Action: UTI: 100 mg PO q12h x 7 days
  11. Pediatrics, 128 (2011), pp